Table 1.
Strengths | Weaknesses | Opportunities | Threats | |
---|---|---|---|---|
ELISA | Flexibility Commercial kits |
Multistep Time consuming |
Detection of EV from different sources Affordable Automation available |
Development of biosensors Multiple-targeted detection systems |
LFIA | Cost-effective on-site detection | Lack of sensitivity | Potential portable detectors | Development of more robust systems |
NTA | Measurement and quantification | Not affordable/available for research groups | Phenotyping of EV sub-populations Applications in drug delivery systems |
AF4 enables EV fractionation |
AF4 | Size fractionation High reproducibility |
Requires skilled operator | Potential clinical and pharmaceutical applications | Eluted fractions may not be used for further functional studies |